Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . December 9th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chronic Hepatitis C - Enzyme not indicative of sustained response after interferon
Hepatectomy - Postsurgical hepatitis linked to shortened survival
Cryoglobulinemia - Gene rearrangements frequent in hepatitis C patients
Drug Resistance - Gene transfer sensitizes liver cancer cells to chemotherapy
Hepatitis C Risk Factors - Virus thrives in sweat glands of chronic hepatitis C patients
Liver Cancer Therapy - Copper chelator trientine mediates liver cancer killing
Liver Transplantation - Time an enemy to liver cancer patients awaiting organ donation
Adverse Drug Effects - Profiles for sulphasalazine and mesalazine don't differ
Allograft Failure - Hepatitis C pathogenesis is influenced by cytomegalovirus
Complementary and Alternative Medicine - Chinese herbal medicine + interferon effectively treat chronic hepatitis B
Disease Markers - HCV infection with normal ALT levels results in less severe liver disease
Drug Interactions - Atorvastatin and diltiazem associated with rhabdomyolysis/acute hepatitis case
Epidemiology - Common source but differing signs, symptoms found in acute HCV outbreak
Finance - Company reports loss from operations was $39.6M
Fulminant Hepatitis B - Cytokine imbalance may play role in inflammation leading to liver damage
Hepatitis B - Six-month phase IIB data of Telbivudine released
Hepatitis B Therapy - Fatal viral reactivation reported after discontinuation of nucleoside analogues
Hepatitis B Therapy - Six months of oral ganciclovir ineffective against lamivudine-resistant HBV
Hepatitis B Virology - Weak protein-protein interactions can drive assembly of HBV capsids
Hepatitis C - FDA approves HCV qualitative assay
Hepatitis C - Priority Healthcare Corp. selected as the distributor for Pegasys Sampling Program
Hepatitis C Therapy - Best interferon therapy strategy depends on viral genotype, study finds
Hepatitis C Therapy - Infergen combination therapy more effective than Rebetron
Hepatitis D Therapy - Prenylation inhibitor prevents infectious hepatitis D virus particle production
Hepatopulmonary Syndrome - Hypoxemia can be resolved after liver transplantation
Influenza - Shire announces vaccines alliance
Liver Cirrhosis - Cryoglobulinemia may predict cirrhosis risk in chronic hepatitis C patients
Liver Fibrosis - Predictive model could enable many chronic hepatitis C patients avoid biopsy
Liver Fibrosis - Study questions predictive value of ALT levels in hepatitis C patients
Liver Fibrosis - Tissue inhibitor of metalloproteinases-1 attenuates resolution in mouse model
Liver Transplantation - Centrilobular fibrosis is not associated with hepatitis in children
Liver Transplantation - Lamivudine therapy is effective against de novo hepatitis B infection
Liver Transplantation - Slowly tapering off steroids protects graft against hepatitis C recurrence
Viral Liver Disease - Study examines regulatory mechanisms for immune complex levels
Virology - Key compounds donated to University of Arizona Foundation
Virology - Location of transactivating and proapoptotic functions found in X proteins
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
